Is Avalo Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: AVTX) stock is to Hold AVTX stock.
Out of 2 analysts, 0 (0%) are recommending AVTX as a Strong Buy, 1 (50%) are recommending AVTX as a Buy, 0 (0%) are recommending AVTX as a Hold, 1 (50%) are recommending AVTX as a Sell, and 0 (0%) are recommending AVTX as a Strong Sell.
What is AVTX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: AVTX) forecast ROE is N/A, which is considered weak.
What is AVTX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year AVTX price target, the average AVTX price target is $6.00, with the highest AVTX stock price forecast at $9.00 and the lowest AVTX stock price forecast at $3.00.
On average, Wall Street analysts predict that Avalo Therapeutics's share price could reach $6.00 by May 10, 2024. The average Avalo Therapeutics stock price prediction forecasts a potential upside of 107.61% from the current AVTX share price of $2.89.
What is AVTX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: AVTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.